CYP2C19 and acute coronary syndrome: Second, our analysis was limited to elective PCI patients only, while the correlation between platelet reactivity and CYP2C19 genotype with clinical outcome is stronger in high risk patients, for example after acute coronary syndrome (ACS) [32].